Beyond the brain: widespread pathology in Huntington's disease

被引:258
|
作者
van der Burg, Jorien M. M. [1 ]
Bjorkqvist, Maria [1 ]
Brundin, Patrik [1 ]
机构
[1] Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden
来源
LANCET NEUROLOGY | 2009年 / 8卷 / 08期
基金
瑞典研究理事会;
关键词
TRANSGENIC MOUSE MODEL; CHOLESTEROL-BIOSYNTHESIS PATHWAY; PITUITARY-ADRENAL AXIS; PERIPHERAL-BLOOD CELLS; EXPANDED CAG REPEAT; R6/2; MOUSE; GENE-EXPRESSION; WEIGHT-LOSS; INCREASED APOPTOSIS; DIABETES-MELLITUS;
D O I
10.1016/S1474-4422(09)70178-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a polyglutamine stretch in the huntingtin protein. Today, more than 15 years after the genetic defect underlying HD was discovered, the pathogenesis is still not well understood and there is no adequate treatment. Research into this disorder has conventionally focused on neurological symptoms and brain pathology, particularly neurodegeneration in the basal ganglia and cerebral cortex. Mutant huntingtin is, however, ubiquitously expressed throughout the body. Indeed, contrary to earlier thinking, HD is associated with abnormalities in peripheral tissues. These abnormal changes are not all secondary to brain dysfunction, but most seem to be directly caused by expression of mutant huntingtin in peripheral tissues. In this article, we highlight this emerging field of research and how it might affect our understanding of the pathogenesis of this disease, the development of novel biomarkers of disease progression, and the identification of new potential treatments.
引用
收藏
页码:765 / 774
页数:10
相关论文
共 50 条
  • [1] Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway
    Barry, Joshua
    Bui, Minh T. N.
    Levine, Michael S.
    Cepeda, Carlos
    NEUROBIOLOGY OF DISEASE, 2022, 162
  • [2] Widespread Gene Delivery to the Nonhuman Primate Brain for the Treatment of Huntington's Disease
    Hadaczek, Piotr
    Stanek, Lisa
    Ciesielska, Agnieszka
    Pivirotto, Philip
    O'Riordan, Catherine
    Mastis, Bryan
    Sebastian, Waldy San
    Forsayeth, John
    Cheng, Seng H.
    Bankiewicz, Krystof S.
    Shihabuddin, Lamya S.
    MOLECULAR THERAPY, 2016, 24 : S246 - S246
  • [3] Huntington's disease: Brain imaging in Huntington's disease
    Johnson, Eileanoir B.
    Gregory, Sarah
    BRAIN IMAGING, 2019, 165 : 321 - 369
  • [4] Huntington's disease - A predictor of pathology
    Rothwell, JC
    NATURE, 2000, 403 (6769) : 495 - 496
  • [5] Clinic and pathology of the Huntington's disease
    Schroeder, K
    JOURNAL FUR PSYCHOLOGIE UND NEUROLOGIE, 1931, 43 : 183 - 201
  • [6] Beyond pathology: APP, brain development and Alzheimer's disease
    Soldano, Alessia
    Hassan, Bassem A.
    CURRENT OPINION IN NEUROBIOLOGY, 2014, 27 : 61 - 67
  • [7] Gangliosides in Huntington's disease and beyond
    Sipione, S.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 55 - 55
  • [8] Widespread Brainstem Neurodegeneration in Huntington's Disease (HD)
    Rueb, Udo
    Vonsattel, Jean Paul G.
    Heinsen, Helmut
    Korf, Horst-Werner
    NEUROPATHOLOGY OF HUNTINGTON'S DISEASE: CLASSICAL FINDINGS, RECENT DEVELOPMENTS AND CORRELATION TO FUNCTIONAL NEUROANATOMY, 2015, 217 : 83 - 90
  • [9] The early cellular pathology of Huntington's disease
    Li, XJ
    MOLECULAR NEUROBIOLOGY, 1999, 20 (2-3) : 111 - 124
  • [10] RNA Related Pathology in Huntington's Disease
    Neueder, Andreas
    Bates, Gillian P.
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 85 - 101